The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review
Abstract
Diabet. Med. 29, 164–175 (2012) Background Depression is common in patients with Type 1 or Type 2 diabetes, has a strong negative impact on the quality of life of patients and is associated with poor outcomes and higher mortality rates. Several guidelines encourage screening of patients with diabetes for depression. It is unclear which depression screening tools are currently being used in people with diabetes and which are most appropriate. Methods A systematic review was conducted to examine which depression screening instruments are currently being used in diabetes research, and the operating characteristics of these tools in diabetes populations. Literature searches for the period January 1970 to October 2010 were conducted using MEDLINE, PSYCH‐INFO, ASSIA, SCOPUS, ACADEMIC SEARCH COMPLETE, CINAHL and SCIENCE DIRECT. Results Data are presented for the 234 published studies that were examined. The Beck Depression Inventory and the Centre for Epidemiologic Studies Depression Scale were the most popular screening tools (used in 24% and 21% of studies). Information on the cultural applicability of screening tools was mostly unavailable and, where reported, included only details of the language translation process. A small number of studies reported reliability data, most of which showed moderate–good sensitivity and specificity but a high rate of false positives. Conclusions Although a range of depression screening tools have been used in research, there remains few data on their reliability and validity. Information on the cultural applicability of these instruments is even scantier. Further research is required in order to determine the suitability of screening tools for use in clinical practice and to address the increasing problem of co‐morbid diabetes and depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813 · cited 1×
“(SDS) (8%; 18/234) [25], which has been used more commonly in people with Type 2 rather than Type 1 diabetes.”
BackgroundSpitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
Assessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Assessment of Diabetes-Related Distress
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Welch, G., Jacobson, A. M., Aponte, J. E., & Schwartz, C. E. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.754 · Cited by 1,497
Psychiatric Illness in General Practice: A Detailed Study Using a New Method of Case Identification
Goldberg, D. P., & Blackwell, B. (1970) · BMJ · doi:10.1136/bmj.2.5707.439 · Cited by 1,121
for the European Depression in Diabetes (EDID) Research Consortium, Nouwen, A., Winkley, K., Twisk, J., Lloyd, C. E., Peyrot, M., Ismail, K., & Pouwer, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1874-x · Cited by 756
Self-citationThe problem areas in diabetes scale: an evaluation of its clinical utility
Welch, G. W., Jacobson, A. M., & Polonsky, W. H. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.760 · Cited by 664
Snoek, F. J., Pouwer, F., Welch, G. W., & Polonsky, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1305 · Cited by 444
Self-citation
Cited by
Holt, R. I. G., de Groot, M., & Golden, S. H. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0491-3 · Cited by 506
Self-citationFisher, L., Gonzalez, J. S., & Polonsky, W. H. (2014) · Diabetic Medicine · doi:10.1111/dme.12428 · Cited by 470
“A recent review of self-report measures of depression for adults with diabetes underscores the problem further: 44–77% of positive screens for major depressive disorder in adults with diabetes were likely false positives [36].”
BackgroundLuoni, C., Bisulli, F., Canevini, M. P., De Sarro, G., Fattore, C., Galimberti, C. A., Gatti, G., La Neve, A., Muscas, G., Specchio, L. M., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03325.x · Cited by 287
Kovacs Burns, K., Nicolucci, A., Holt, R. I. G., Willaing, I., Hermanns, N., Kalra, S., Wens, J., Pouwer, F., Skovlund, S. E., Peyrot, M., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12239 · Cited by 272
Self-citationDepression and diabetes: Treatment and health-care delivery
Petrak, F., Baumeister, H., Skinner, T. C., Brown, A., & Holt, R. I. G. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00045-5 · Cited by 166
Self-citationDepression in adults in the T1D Exchange Clinic Registry
Trief, P. M., Xing, D., Foster, N. C., Maahs, D. M., Kittelsrud, J. M., Olson, B. A., Young, L. A., Peters, A. L., Bergenstal, R. M., Miller, K. M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1867 · Cited by 93
“(31) raise the concern that these tools have a high rate of false positives, although they conclude that the PHQ-9 is valid and reliable with high sensitivity and specificity for major depression.”
BackgroundPrevalence of depression in Type 1 diabetes and the problem of over‐diagnosis
Fisher, L., Hessler, D. M., Polonsky, W. H., Masharani, U., Peters, A. L., Blumer, I., & Strycker, L. A. (2016) · Diabetic Medicine · doi:10.1111/dme.12973 · Cited by 90
Gonzalez, J. S., Kane, N. S., Binko, D. H., Shapira, A., & Hoogendoorn, C. J. (2016) · Diabetes Care · doi:10.2337/dc16-1657 · Cited by 80
Jones, A., Vallis, M., & Pouwer, F. (2015) · Diabetic Medicine · doi:10.1111/dme.12620 · Cited by 79
Self-citationAlexakis, C., Kumar, S., Saxena, S., & Pollok, R. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14171 · Cited by 69
“However, research on depression screening tools in other chronic illness has highlighted issues with overall validity and reliability.(44) Ideally, the diagnosis of depression for the purposes of this research question would be made following objective assessment by a mental health specialist.”
BackgroundNaik, A. D., Hundt, N. E., Vaughan, E. M., Petersen, N. J., Zeno, D., Kunik, M. E., & Cully, J. A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.8634 · Cited by 57
Iversen, M. M., Tell, G. S., Espehaug, B., Midthjell, K., Graue, M., Rokne, B., Berge, L. I., & Østbye, T. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.09.006 · Cited by 56
The Changing Nature of Mortality and Morbidity in Patients with Diabetes
Pearson-Stuttard, J., Buckley, J., Cicek, M., & Gregg, E. W. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.001 · Cited by 48
Bruce, D. G., Davis, W. A., Dragovic, M., Davis, T. M. E., & Starkstein, S. E. (2016) · Depression and Anxiety · doi:10.1002/da.22523 · Cited by 39
WHO‐5 and BDI‐II are acceptable screening instruments for depression in people with diabetes
Rauwerda, N. L., Tovote, K. A., Peeters, A. C. T. M., Sanderman, R., Emmelkamp, P. M. G., Schroevers, M. J., & Fleer, J. (2018) · Diabetic Medicine · doi:10.1111/dme.13779 · Cited by 36
Apathy in Older Patients with Type 2 Diabetes
Bruce, D. G., Nelson, M. E., Mace, J. L., Davis, W. A., Davis, T. M. E., & Starkstein, S. E. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.09.010 · Cited by 26
Metadata
- Authors
- Roy, T., Lloyd, C. E., Pouwer, F., Holt, R. I. G., & Sartorius, N.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2012-01-11
- Volume
- 29
- Issue
- 2
- Pages
- 164-175
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1764171741
- Cited by
- 158
- References
- 18
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.